Akari Therapeutics, Plc (AKTX)
Company Info
| ISIN | US00972G1085 |
|---|---|
| CUSIP | 00972G108 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $19.97M |
|---|---|
| EPS | -$5.55 |
| EBITDA (TTM) | -$21.23M |
| Year Range | $2.81 - $13.40 |
| Target Price | $55.00 |
| Short % | 0.19% |
| Short Ratio | 0.49 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Akari Therapeutics, Plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Akari Therapeutics, Plc had a return of -61.56% year-to-date (YTD) and -71.51% in the last 12 months. Over the past 10 years, Akari Therapeutics, Plc had an annualized return of -52.32%, while the S&P 500 had an annualized return of 10.00%, indicating that Akari Therapeutics, Plc did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | 8.15% | -5.04% |
| 6 months | -9.51% | 4.58% |
| Year-To-Date | -61.56% | 11.69% |
| 1 year | -71.51% | 16.58% |
| 5 years (annualized) | -39.41% | 8.16% |
| 10 years (annualized) | -52.32% | 10.00% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -47.33% | -0.33% | -2.32% | -3.90% | 46.82% | -36.90% | 25.40% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Akari Therapeutics, Plc (AKTX) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
AKTX Akari Therapeutics, Plc | -0.76 | ||||
^GSPC S&P 500 | 1.04 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Akari Therapeutics, Plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Akari Therapeutics, Plc is 99.94%, recorded on Mar 30, 2023. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.94% | May 23, 2013 | 2261 | Mar 30, 2023 | — | — | — |
Volatility Chart
The current Akari Therapeutics, Plc volatility is 23.31%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.